Intraoperative slow-release dexamethasone intravitreal implant (Ozurdex) in epiretinal membrane peeling surgery: a prospective randomized controlled trial

Purpose: This study aimed to determine the efficacy of the dexamethasone (DEX) intravitreal implant for the regression of macular edema and the improvement of best-corrected visual acuity (BCVA) after the removal of idiopathic epiretinal membrane (ERM).Methods: This prospective randomized controlled...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Siying Li, Qiaozhu Zeng, Li Zhu, Wenbo Liu, Yujing Li, Jiarui Li, Xiaoxin Li, Mingwei Zhao, Jinfeng Qu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-09-01
coleção:	Frontiers in Pharmacology
Assuntos:	epiretinal membrane pars plana vitrectomy Ozurdex central retinal thickness best-corrected visual acuity
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1219861/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!